LSIP, LLC
11Patents
11Active
11Granted
48Portfolio score
Filing activity: Apr 13, 2009 → Oct 2, 2013 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9216172B2 | Method for determining effectiveness of cancer treatment by assessing the presence of a KIF5B-RET chimeric gene | Physics | 34 | Active |
| US8956868B2 | Induced pluripotent stem cells produced with a connexin inhibitor and a TGF-β signaling inhibitor | Chemistry; Metallurgy | 0 | Active |
| US8946185B2 | Agent for suppressing expression of dominant allele | Chemistry; Metallurgy | 0 | Active |
| US9176236B2 | Device for measuring radiation intensity of small sealed radiation source for cancer therapy | Human Necessities | 0 | Active |
| US8975021B2 | Method for detecting rhabdomyosarcoma using sample derived from body fluid | Chemistry; Metallurgy | 0 | Active |
| US8759323B2 | Protein phosphatase inhibitor | Chemistry; Metallurgy | 0 | Active |
| US8686127B2 | Apoptosis inducer | Chemistry; Metallurgy | 0 | Active |
| US8980264B2 | Mouse anti-Aggrus monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US9465030B2 | Kit for diagnosing malignant melanoma | Physics | 0 | Active |
| US9376665B2 | Method for producing intestinal cells | Physics | 0 | Active |
| US9238812B2 | Agent for suppressing expression of dominant mutant gene | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.